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Abroad spectrum ofmutations inPTEN, encod-
ing a lipid phosphatase that inactivates the
P13-K/AKT pathway, is found associated with
primary tumors. Some of thesemutations occur
outside the phosphatase domain, suggesting
that additional activities of PTEN function in tu-
mor suppression. We report a nuclear function
for PTEN in controlling chromosomal integrity.
Disruption of Pten leads to extensive centro-
mere breakage and chromosomal transloca-
tions. PTEN was found localized at centromeres
and physically associated with CENP-C, an inte-
gral component of the kinetochore. C-terminal
PTEN mutants disrupt the association of PTEN
with centromeres and cause centromeric insta-
bility. Furthermore,Ptennull cells exhibit sponta-
neous DNA double-strand breaks (DSBs). We
show thatPTENacts on chromatin and regulates
expression of Rad51, which reduces the inci-
dence of spontaneous DSBs. Our results dem-
onstrate that PTEN plays a fundamental role
in the maintenance of chromosomal stability
through the physical interaction with centro-
meres and control of DNA repair. We propose
thatPTENactsasaguardianofgenome integrity.
INTRODUCTION
PTEN was identified in 1997 as a tumor-suppressor gene
located on 10q23.3 (Li et al., 1997). PTEN is mutated in
a wide variety of solid tumors, which mainly include glio-
blastomas, endometrial carcinomas, breast carcinomas,
and prostate carcinomas (Di Cristofano and Pandolfi,
2000; Eng, 2003; Li et al., 1997; Steck et al., 1997). A broad
spectrum of somatic PTEN mutations in primary tumors
has been reported and includes null mutations, missensemutations, and truncations, which span from the PTEN
promoter, the phosphatase domain in the N terminus,
the C2 domain in the middle, and to the C terminus of
PTEN (Eng, 2003). Germline mutations of PTEN have
also been found in cancer-susceptibility syndromes
such as Cowden syndrome, which is characterized by
a high risk of breast and thyroid cancers (Di Cristofano
et al., 1998; Eng, 2003). Mice heterozygous for Pten de-
velop spontaneous tumors (Di Cristofano et al., 1998;
Podsypanina et al., 1999; Stambolic et al., 2000; Suzuki
et al., 1998). Conditional tissue-specific disruption of
Pten also leads to different tumors in the affected tissues
(Wang et al., 2003; Yilmaz et al., 2006). PTEN encodes
a major lipid phosphatase that functions in the phosphoi-
nositide 3-kinase (PI3-K) signaling cascade. Loss of PTEN
leads to the activation of the PI3-K/AKT cascade and stim-
ulates cell growth and proliferation (Stambolic et al., 1998;
Sun et al., 1999). Therefore, PTEN may control normal cell
survival through its regulation of PI3-K signaling (Cully
et al., 2006). However, emerging evidence is suggestive
of other PTEN functions that are unrelated to PI3-K/AKT
signaling. The fact that some PTEN mutations occur in re-
gions other than the phosphatase domain suggests that
PTENmay have other functions in cellular activities and tu-
mor suppression (Eng, 2003;Waite and Eng, 2002). There-
fore, it is crucial to discern new PTEN functions in order to
fully understand how PTEN suppresses tumorigenesis
and how loss of PTEN predisposes to tumorigenicity.
As a hallmark of cancer (Albertson et al., 2003), chromo-
somal instability may result from inaccurate chromosomal
segregation during mitosis, which may occur in the pres-
ence of faulty structural components such as centrosome
amplification or dysfunctional centromeres or kineto-
chores (Yuen et al., 2005). The centromere is a unique
and functional chromosomal domain responsible for the
accurate segregation of chromosomes during mitosis
(Cleveland et al., 2003; Henikoff et al., 2001). The centro-
mere provides the platform or the foundation for the
assembly of the kinetochore. Centromeres consist of
a-satellite DNA and sequence-specific DNA-binding pro-
teins. Centromere function is highly conserved, but theCell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 157
satellite sequences are divergent. Thus the major focus of
centromere studies is on centromeric proteins. There are
a number of known centromere-specific binding proteins,
which mainly include centromere proteins CENP-A,
CENP-B, and CENP-C, all of which are sequence-specific
DNA-binding proteins (Carroll and Straight, 2006). CENP-
C is an integral component of the inner kinetochore that
forms a functional centromere (Fukagawa et al., 1999).
Both CENP-A and CENP-C bind exclusively to the centro-
mere and are necessary for kinetochore action and ac-
curate segregation during mitosis (Kalitsis et al., 1998;
Regnier et al., 2005; Tomkiel et al., 1994). Centromere
breakage may destroy the foundation for the assembly of
the kinetochore, leading to improper sister-chromatid seg-
regation and chromosomal instability.
Chromosomal translocations are often caused by
defects in repair mechanisms for DNA double-strand
breaks (DSBs). Homologous recombination-directed re-
pair (HDR) is a major mechanism for DSB repair (Pierce
et al., 2001). Impairment of the HDR pathway may cause
defects in DSB repair and contribute to genomic instability
(Mills et al., 2003). HDR is primarily controlled by the DNA-
repair family that includes Rad51, BRCA1, and BRCA2
(Pastink et al., 2001; Tutt and Ashworth, 2002). Disruption
of Rad51 leads to extensive chromosomal aberrations in
mouse cells due to defects in HDR (Smiraldo et al., 2005).
It is well known that p53 plays a fundamental role in
the maintenance of genome and chromosomal stability
(Fukasawa et al., 1996; Livingstone et al., 1992; Yin et al.,
1992). As a powerful tumor suppressor, PTEN may also
maintain normal chromosomal structure and function. It
has been reported that lack of PTEN expression is associ-
ated with aneuploidy in human primary breast cancers
(Puc et al., 2005). In this paper, we demonstrate that
PTEN plays a crucial role in the maintenance of chromo-
somal stability and that nuclear PTEN controls chro-
mosomal integrity through novel mechanisms. First, we
observed that loss of PTEN leads to extensive centromere
breakage. Furthermore, we found that PTEN is associated
with centromeres specifically by its interactions with
CENP-C. Interestingly, PTEN mutants retaining their
phosphatase domain interfere with the interaction be-
tween wild-type PTEN and the centromere, resulting in
the destruction of chromosomal stability. Moreover, loss
of PTEN results in defects in DSB repair. We found that
PTEN regulates Rad51 at the transcriptional level and
thus contributes to the stability of chromosomes through
modulation of the DSB-repair system. Our findings reveal
that through its role in the nucleus PTEN maintains chro-
mosomal stability and provide a mechanistic basis for
this novel tumor-suppressor function.
RESULTS
Essential Role of PTEN in Controlling Chromosomal
Integrity
To determine the potential role of PTEN in maintaining
chromosomal stability, we examined the chromosomal158 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.status in mouse-model cell systems that included mouse
embryonic fibroblasts (MEFs) and mouse embryonic stem
cells (ES): (1) wild-type and Pten null MEFs (Pten+/+ MEFs
and Pten/MEFs; Li et al., 2002; Sun et al., 1999) and (2)
wild-type and Pten null ES (Pten+/+ ES and Pten/ ES).
We examined chromosomal structure microscopically
using fluorescence in situ hybridization (FISH). A fluores-
cent Cy3-labeled peptide nucleic acid (PNA) probe that
was specific for telomeric sequences was used to localize
telomeres. In addition, the chromosomes were counter-
stained with DAPI, which binds with a high affinity to the
AT-rich centromeric heterochromatin of the mouse chro-
mosomes. One of the most remarkable features of
Pten/ MEF metaphases is the abundance of centro-
meric instability manifested as centromere fragments
(CF; Figure 1; Table S1A). Representative metaphase
spreads from Pten+/+ MEFs and Pten/MEFs hybridized
with the telomere-specific probe are illustrated in Figures
1A–1C. Magnifications of selected areas in themetaphase
spreads (Figures 1Bb1–1Cc2; DAPI and Cy3 costained
with corresponding inverted grayscale) are provided for
enhanced visualization of centromere fragments with telo-
meric signals. Two prominent, intact telomeres were
observed in almost all of the centromere fragments pres-
ent in Pten/ MEFs (Figure 1Bb1), indicating that break-
age preferentially occurs in the centromeric regions.
Twenty percent of the centromere fragments appeared
as miniature chromosomes containing four telomeric
signals, which were likely produced by the fusion of two
individual centromere fragments (Figure 1Bb2). We also
found Robertsonian centromere fusion (Rob) in Pten/
MEFs (Figure 1Cc1) but not in Pten+/+ MEFs (Figures 1A
and 1D). In addition to increased frequency of centro-
mere-associated chromosomal instability, we found Rob-
ertsonian and non-Robertsonian types of chromosomal
translocations in Pten-deficient MEFs. As multicolor fluo-
rescence in situ hybridization (M-FISH) allows unambigu-
ous identification of every mouse chromosome, this
technique was utilized to precisely identify the unstable
chromosomes involved in aberration formation in Pten/
MEFs (Figures 1E and 1F) in comparison with Pten+/+
MEFs (Figure 1D). Using both telomere fluorescence in
situ hybridization (T-FISH) andM-FISH, we detected chro-
mosomal aberrations in almost every metaphase spread
of Pten/MEFs. Different types of chromosomal anoma-
lies were observed in Pten/ MEFs, including breaks
(chromosome and chromatid types), fragments (centric
and acentric), translocations (reciprocal and nonrecipro-
cal), and fusions. The types and frequencies of spontane-
ous chromosomal aberrations as well as the number of
each that was detected using T-FISH and M-FISH are
listed in Table S1A. The total number of centromere frag-
ments detected in Pten/ and Pten+/+ MEFs differs by
16-fold (2.01 per metaphase for Pten null cells versus
0.125 per metaphase for Pten wild-type cells; Table
S1B). While no chromosomal translocations of any kind
were detectable in Pten+/+ MEFs (Figure 1D), chromo-
somal translocations and centromere breakages were
Figure 1. Spontaneous Chromosomal
Instability in Pten Null MEFs
(A–C) Telomere fluorescence in situ hybridiza-
tion (T-FISH) was performed using a Cy3-
labeled peptide nucleic acid (PNA) telomeric
probe. Representative metaphase spreads
from wild-type and Pten null cells hybridized
with a Cy3 telomeric probe are shown. The
merged images of DAPI (blue) and Cy3-labeled
(red) metaphase spreads are shown in the top
panel. The selected regions of metaphase
spreads from Pten/ mouse embryo fibro-
blasts (MEFs) are magnified in the lower panel
to show centromere fragments (CF) and Rob-
ertsonian centromeric fusion (Rob), indicated
by arrows. Metaphase spreads counterstained
for DNA with DAPI are given below (b1–c2) in
inverted grayscale for visual enhancement.
(D–F) Multicolor fluorescence in situ hybridiza-
tion (M-FISH) analysis of mouse chromo-
somes. Metaphase spreads were hybridized
with M-FISH probes comprising a cocktail of
DNA from all mouse chromosomes. The chro-
mosomes involved in translocations are
marked by arrows and chromosome numbers.
(e1–f2) Representative partial metaphase
spreads from Pten/ MEFs are shown. Note
the reciprocal translocation between chromo-
some 2 and chromosome 6 (f1 and f2).observed in Pten/ MEFs, as revealed by M-FISH (Fig-
ures 1E, 1Ee1, 1F, 1Ff1, and 1Ff2; Table S1A, 0.95 trans-
locations per metaphase). We also found complex trans-
locations involving two or more chromosomes in 30% of
the metaphases from Pten/MEFs. We detected one re-
ciprocal translocation between chromosomes 2 and 6
(Figures 1Ff1 and 1Ff2) and another reciprocal transloca-
tion involving chromosomes 14 and 15 (Table S1A).
We next investigated whether the centromere-associ-
ated chromosomal instability also exists in Pten-deficient
ES cells (Figures S1A–S1D). In corroboration with MEFs,
Pten-deficient ES cells also showed a substantial in-
crease in the frequency of centromere fragments (1.1
per metaphase) compared to that in wild-type ES cells
(0.12 per metaphase) (Table S1B; Figures S1A and S1B
versus Figures S1C and S1D). It is worthwhile to point
out that the frequency of centromere-associated chro-
mosomal instability was much less in ES cells compared
to that in MEFs. Taken together, these results illustrate
that Pten disruption confers a phenotype of chromo-
somal instability with a structural signature of centromere
breakage.Localization of PTEN at Centromeres
and Its Physical Interaction with CENP-C
The predominance of centromere breakage in every
Pten/MEF metaphase spread that was examined high-
lights a fundamental role of PTEN in stabilizing the centro-
meric regions. We therefore hypothesized that PTEN may
be a component of the centromere that contributes to sta-
bilization of an intact chromosome. To determine whether
PTEN is localized at the centromere, a PTEN-specific an-
tibody was used in conjunction with an antibody known to
specifically react with centromeres from CREST patients
(Moroi et al., 1980) to localize both PTEN and centromeres
in Pten+/+ MEFs. Figure 2A shows the intranuclear locali-
zation of PTEN (Figure 2Aa, green) and the typical punc-
tate centromere distribution (Figure 2Ab, red). The PTEN
signal is undetectable in Pten/MEFs (Figure 2Ad), con-
firming the specificity of the PTEN antibody (Figure 2Aa).
Immunofluorescence analysis reveals the overlap between
the PTEN signal (in green) and the centromere (in red) as a
yellow signal of discrete speckles (Figure 2Ac), indicating
that a significant portion of nuclear PTEN colocalizes with
centromeres in Pten+/+ MEFs. In contrast, no overlap ofCell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 159
Figure 2. Centromeric Localization of
PTEN and Its Association with Centro-
mere Protein
(A) Confocal analysis of PTEN localization at
centromere regions. Pten+/+ (a, b, and c) and
Pten/MEFs (d, e, and f) were immunostained
for both PTEN (fluorescein; a and d) and centro-
meres (Texas red; b and e) following a double
immunofluorescent procedure. A representa-
tive cell in each image (1, 2, and 3 for Pten+/+
and 4, 5, and 6 for Pten/MEFs) was enlarged
for visual enhancement. The yellow signal in the
merged confocal images (c and 3) represents
an overlapping spatial relationship between
PTEN and centromeres.
(B) PTEN physically associates with centro-
mere protein. Cell lysates from Pten+/+ and
Pten/ MEFs were immunoprecipitated with
an anti-PTEN monoclonal antibody and sub-
jected to western blotting with an anticentro-
mere antibody.
(C) PTEN specifically interacts with CENP-C.
PTEN immunoprecipitates prepared from
Pten+/+ and Pten/ MEFs were subjected to
western blotting using a CENP-C-specific
antibody.
(D) Reciprocal examination of physical interac-
tion between PTEN and CENP-C. CENP-C
immunoprecipitates were subjected to western
blotting using the anti-PTEN antibody. Exacta-
Cruz reagents (Santa Cruz) were used to re-
duce the immunoglobulin G (IgG) heavy-chain
background.yellow signal is visible in simultaneously costained
Pten/ MEFs (Figure 2Af). The centromeric localization
of PTEN prompted us to investigate the potential interac-
tion of PTEN with centromere-specific protein compo-
nents. Immunoprecipitation (IP) of PTEN from Pten-
proficient MEF cell lysates using a PTEN antibody in fact
revealed at approximately 140 kDa a PTEN-associated
protein that was recognized by the anti-centromere anti-
body (Figure 2B, lane 1). In contrast, this protein was un-
detectable in immunoprecipitates from Pten/ MEFs
(Figure 2B, lane 2). CREST antiserum reacts with multiple
centromere proteins (Earnshaw and Rothfield, 1985), in-
cluding CENP-C (140 kDa), which localizes at the inner
core of the kinetochore complex (Saitoh et al., 1992). We
wished to determine whether the PTEN-associated 140
kDa protein that was recognized by the anti-centromere
antibody (Figure 2B) could in fact be CENP-C. This possi-
bility was confirmed by using a CENP-C-specific antibody
that detected the 140 kDa PTEN-associated protein in
Pten+/+ MEFs (Figure 2C, lane 1). Consistently, this protein
component does not exist in precipitates from Pten/160 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.MEFs (Figure 2C, lane 2). Furthermore, PTEN was de-
tected in an anti-CENP-C immunoprecipitated complex
from Pten+/+ MEFs but not from Pten/MEFs (Figure 2D,
lane 1 versus lane 2). These observations clearly demon-
strate that PTEN physically localizes in the centromere
region and interacts with constitutive centromeric pro-
tein. Its location at centromeres indicates that PTEN
may be involved in maintaining the functional integrity
of chromosomes. Disruption of Pten, therefore, is ex-
pected to weaken the chromosomal architecture and
lead to chromosomal breakage at the centromere region,
which is a phenotype most frequently observed in Pten
null cells.
Physical Association of PTEN with Centromeres
Is Crucial for Chromosome Stability
Because PTEN functions mainly through its phosphatase
activity, we examined whether this novel role of PTEN in
centromere maintenance is dependent on that activity.
For this purpose, we generated a point mutation within
the phosphatase domain of PTEN (PTEN.C124S) that
Figure 3. Phosphatase-Independent
Association of PTEN with Centromere
Protein
(A) The C-terminal region of PTEN but not the
phosphase activity is required for PTEN associ-
ation with a 140 kDa centromere protein.
Pten/ MEFs were transfected with a PTEN-
expression plasmid, a phosphatase-deficient
PTEN (PTEN.C124S), a His-tagged truncated
PTEN mutation (HisPTEN189), and pcDNA3.
The ectopic PTEN was immunoprecipitated
with either a PTEN antibody or an anti-His anti-
body. PTEN-associated centromere proteins
were then detected by western blotting using
the centromere antibody.
(B) PTEN associates with CENP-C in a phos-
phatase-independent manner. Lysates from
indicated cells were immunoprecipitated with
a PTEN monoclonal antibody and subjected
to western blotting with a CENP-C-specific
antibody.
(C) Reciprocal detection of interaction between
mutant PTEN and CENP-C. Cell lysates were
immunoprecipitated by the anti-CENP-C anti-
body and then subjected to western blotting
using the anti-PTEN or anti-His antibody as
indicated. Western blotting of lysates from
Pten/ MEF/HisPTEN189 using the anti-His
antibody was used as a control for
HisPTEN189 expression (right panel, lane 2).inactivates the phosphatase activity (Maehama and
Dixon, 1998). To test whether this PTEN mutant retains
its association with centromere protein CENP-C, we
expressed this mutant PTEN in Pten/ MEFs and per-
formed reciprocal IP-western analysis of CENP-C and
mutant PTEN interaction. As shown in Figures 3A–3C,
PTEN.C124S still interacts with CENP-C, demonstrating
that their association is independent of the phosphatase
activity. Our data imply that PTEN may exert its centro-
mere-maintenance function through a phosphatase-inde-
pendent activity. Next, we sought to discern whether the
association of PTEN with centromeres is important for
PTEN function in maintaining centromere integrity and
chromosomal stability. We planned to test whether a
PTEN mutant lacking physical association with centro-
mere components could cause chromosomal instability
in normal cells. In order to screen for amutation that would
interfere with PTEN’s association with CENP-C, we cre-
ated a series of deletion mutants by truncating PTEN
cDNA and tested whether the encoded proteins could still
interact with CENP-C. We generated PTEN-deletion mu-
tants based on the criteria that the same mutants have
been found in human cancers and that they still possess
a functional phosphatase domain. These mutant PTEN
expression vectors were introduced into MEFs, and asso-
ciation of mutant PTEN with CENP-C was examined.
Indeed, we found that one truncated mutant PTEN,PTEN.R189X (designated as PTEN189), loses its binding
affinity for CENP-C (Figure 3A, lane 4 versus lane 2).
PTEN189 is a single mutation of PTEN at codon 189 that
alters its sequence from AGA to TGA to create a stop
codon. The resulting truncated PTEN retains the intact
N-terminal phosphatase domain but lacks the entire C
terminus. The same mutation was reported to occur in
Cowden syndrome, where PTEN mutations are present
in 80% of all patients (Eng, 2003). Patients with Cowden
syndrome develop breast cancer at a frequency between
25%–50% (Eng, 2003). The results shown in Figures 3A
and 3C indicate that the C-terminal domain of PTEN is re-
quired for its association with centromeres and CENP-C
since the truncated mutant PTEN189 no longer interacts
(Figure 3A, lane 4; Figure 3C, right panel, lane 1). Our
data demonstrate that PTEN performs its centromere-
associated function through a phosphatase-independent
mechanism.
PTEN deficiency in tumors is usually caused by muta-
tions in which a mutant form of PTEN is still expressed.
This is similar to what occurs with mutations in the tumor
suppressor p53. Certain mutant forms of p53 have not
only lost their tumor-suppressive function but have also
somehow gained a function as an oncogene (Levine
et al., 1995). We propose that mutant PTEN may also
gain a new function that is harmful to chromosomal stabil-
ity. To test this hypothesis, we sought to determineCell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 161
Figure 4. Chromosomal Instability in
MEFs Expressing the PTEN189 Mutant
(A–D) Primary Pten+/+ MEFs were transfected
with either a PTEN189-expression vector, a
full length PTEN expression vector, or pcDNA3.
T-FISH analysis was performed with meta-
phase spread from MEF/pcDNA3/His (A),
MEF/PTEN (B), and MEF/HisPTEN189 (C and
D). (c1–d3) Magnification of the selected areas
from (C) and (D) showing chromosomal aberra-
tions in Pten+/+ MEF/HisPTEN189: c1, centro-
mere fragments (CF); c2, acentric fragments
(AF); d1, premature centromere separation
(PCS); d2, telomere fusion (TF); d3, chroma-
tid-type break (CtBr). x indicates Robertsonian
centromere fusion (Rob), and y indicates quad-
rivalent (Qua) found in MEF/HisPTEN189.
(E and F) Expression of truncated PTEN,
PTEN189, in Pten+/+ MEFs. Cell lysates from
Pten+/+ MEF/pcDNA3/His and Pten+/+ MEF/
HisPTEN189 were separated in SDS-PAGE
for detection of PTEN189 protein expression
by western blotting with either a PTEN full-
length polyclonal antibody (E), or the anti-His
antibody (F).
(G) Disruption of PTEN-CENP-C interaction by
PTEN189 in MEFs. PTEN protein was immuno-
precipitated by a PTEN monoclonal antibody
and then processed for western blotting using
the anti-CENP-C antibody.
(H) Physical association between endogenous
PTEN and HisPTEN189. HisPTEN189 was im-
munoprecipitated by the anti-His antibody
and then subjected to western blotting using
the anti-PTEN to detect PTEN189-associated
endogenous PTEN.whether the truncated PTEN mutant acts to interfere with
normal PTEN function in maintaining chromosomal stabil-
ity. Cytogenetic analysis was carried out on Pten+/+ MEFs
containing either the control pcDNA3/His vector (Pten+/+
MEF/pcDNA3), the wild-type PTEN expression vector
(Pten+/+ MEF/PTEN), or the pcDNA3/His-tagged PTEN189-
expression vector (Pten+/+ MEF/HisPTEN189). While
MEF/pcDNA3/His cells and MEFs expressing ectopic
wild-type PTEN display normal karyotypes (Figures 4A
and 4B), MEFs expressing the PTEN189 mutant exhibit
both numerical and structural chromosomal changes (Fig-
ures 4C and 4D). There are dramatic chromosomal abnor-
malities inMEFs expressing PTEN189 as listed in Table S2
and shown in Figures 4C and 4D. Particularly, we found
centromere fragments in these MEFs with PTEN189
(Figure 4Cc1). In addition, a significant number of struc-
tural chromosomal aberrations, including acentric frag-
mentation (AF; Figure 4Cc2), telomere fusions (TF;
Figure 4Dd2), chromatid-type breaks (CtBr; Figure 4Dd3),
Robertsonian centromere fusions (Rob; Figure 4x), and
quadrivalents (Qua; Figure 4y) are present in MEFs
expressing PTEN189 (Figures 4C and 4D). Most notably,162 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.premature centromere separation (PCS) was found in
approximately 40% of the metaphases from Pten+/+
MEFs with PTEN189 (Figure 4Dd1). These results indicate
that this PTENmutant is capable of causingmassive chro-
mosomal abnormalities in normal cells. To confirm the
expression of PTEN189, we examined the levels of intact
PTEN and truncated PTEN189 in Pten+/+ MEF/pcDNA3
and Pten+/+ MEF/His-tagged PTEN189. Both wild-type
PTEN and PTEN189 mutant proteins were detectable by
the anti-full-length PTEN antibody (Figure 4E). This
PTEN189 mutant protein was also detected by an anti-
His monoclonal antibody (Figure 4F, lane 2). Because
this occurs in cells transiently expressing the PTENmutant
in the presence of the wild-type PTEN protein, it is possi-
ble that this PTEN mutant can interfere with the physical
interaction between PTEN and centromeres. To test this
possibility, we performed IP-western analysis to detect
the association of wild-type PTEN with CENP-C in the
presence of this PTEN mutant. As shown in Figure 4G,
while PTEN is associated with CENP-C in MEF/pcDNA3,
the interaction between PTEN and CENP-C is greatly di-
minished in the MEFs expressing PTEN189. Interestingly,
ectopic PTEN189 interacts with endogenous wild-type
PTEN (Figure 4H, lane 1). These results indicate that
the PTEN mutant may interfere with the normal function
of PTEN at centromeres. To test this hypothesis, we ex-
amined the physical and spatial relationship between
PTEN189 and centromeres. As shown in Figure S2, there
is no physical interaction between PTEN189 and cen-
tromeres in both Pten+/+ MEFs and Pten/ MEFs
(Figure S2A, lanes 2 and 3), although HisPTEN189 is ex-
pressed in these cells (Figure S2A, lane 1). Interestingly,
the level of phosphorylation of AKT remains unchanged
in MEFs expressing HisPTEN189 (Figure S2B, lane 2 ver-
sus lane 3), indicating that PTEN189 does not interfere
with PTEN function in suppressing AKT activity. Further-
more, immunofluorescent staining for both PTEN189
and centromeres did not show colocalized spots in
Pten+/+ MEFs, although PTEN189 is still localized in the
nucleus (Figure S2C). Our data indicate that PTEN189
blocks the functional association of wild-type PTEN with
centromeres, likely by forming a complex with nuclear
PTEN. Because the truncated PTEN189 mutant that loses
centromere association was derived originally from Cow-
den patients, centromere instability may occur in Cowden
patients. We tested one lymphoblastoid cell line from
a Cowden syndrome patient with a germline PTEN muta-
tion (IVS6 + 1; G > T). This is a splice-site mutation of PTEN
that results in exon 6 skipping; in addition, there are both
a wild-type form of PTEN and a truncated form of PTEN
in these cells (Agrawal et al., 2005). Interestingly, like
PTEN189, this mutant PTEN retains its phosphatase do-
main but loses its C2 domain in its C terminus. As pre-
dicted, there is no detectable interaction between this mu-
tant PTEN and centromeres (data not shown). We then
determined whether there is centromere breakage in
these cells. We used a fluorescein-conjugated pancentro-
meric DNA probe to characterize the centromere-associ-
ated chromosomal instability in human cells. As expected,
there is a high frequency of centromere breakage in Cow-
den lymphoblastoid cells lacking exon 6 (IVS6 + 1; G > T)
comparedwith normal lymphoblastoid cells (Figures S2D–
S2G; Figures S2Ee2, S2Ee3, S2Gg2, and S2Gg3). Inter-
estingly, we also found PCS in these Cowden syndrome
cells (Figures S2Ee1 and S2Gg1). These observations
are consistent with a phenomenon demonstrated with
the truncated PTEN189 mutant. These data indicate that
the C2 domain of PTEN is closely associated with centro-
mere stability in Cowden syndrome.
To precisely evaluate the importance of PTEN-centro-
mere association in centromeric stability, we sought a re-
cessive mutant of PTEN that influences the association of
PTEN with centromeres but does not affect other func-
tions of PTEN. PTEN.R233X (designated as PTEN233)
was derived from Cowden syndrome (Eng, 2003). It is
a single mutation of PTEN at codon 233 from CGA (argi-
nine) to TGA (stop codon), resulting in a truncated PTEN
that retains the intact phosphatase domain. We found
that PTEN233 does not affect PTEN expression but dis-
rupts the association of PTEN with CENP-C. As shownin Figure S3A, the levels of endogenous wild-type PTEN
are similar in both Pten+/+ MEF/pcDNA3 and Pten+/+
MEF/PTEN233 cells with transient expression of
PTEN233. The level of AKT phosphorylation is unchanged
in Pten+/+ MEF/PTEN233 cells (Figure S3A, lane 1 versus
lane 2), indicating that this mutant does not interfere with
endogenous PTEN function as an inhibitor of AKT. As
expected, PTEN-associated CENP-C was detected in
Pten+/+ MEF/pcDNA3 cells (Figure S3B, lane 1). However,
there is no detectable band corresponding to CENP-C in
Pten+/+ MEF/PTEN233 cells (Figure S3B, lane 2), suggest-
ing that this mutant disrupts the interaction between wild-
type PTEN and CENP-C. Furthermore, there is a high fre-
quency of typical centromere fragments in these Pten+/+
MEF/PTEN233 cells (Figures S3Ee1–S3Ee3 and S3Ff1–
S3Ff3) compared with Pten+/+ MEF/pcDNA3 cells (Figures
S3C and S3D). Notably, in Pten+/+ MEF/PTEN233 cells,
we did not find any other chromosomal aberrations such
as PCS that frequently occurred in Pten+/+ MEF/
PTEN189 cells. Interestingly, this mutant is disassociated
from centromeres, although it is located in the nucleus
(Figure S3G). Our observations suggest that this
PTEN233 mutant acts in a recessive manner. Our data
once again demonstrate that physical association of
PTENwith the centromere through its C terminus is crucial
for centromere stability. These data provide an explana-
tion of why there is a high frequency of PTEN mutations
in the C2 domain and C terminus in Cowden syndrome.
Loss of PTEN Leads to Spontaneous DNA DSBs
In addition to the signature anomaly of centromere break-
age, Pten disruption results in other forms of spontaneous
chromosomal aberrations, including random breaks, frag-
mentations, fusions, and translocations (Figure 1; Table
S1A). These may be attributed to defects in the repair of
severe DNA damage such as DSBs (Thiriet and Hayes,
2005). Since inefficient or defective repair of DSBs can
lead to these chromosomal abnormalities, we analyzed
the incidence of spontaneous DSBs in Pten wild-type
and Pten null cells. The frequency of DSBs was estimated
by immunostaining for the phosphorylated form of histone
H2AX (g-H2AX), a widely used marker for DSBs (Foster
and Downs, 2005). Compared to Pten+/+ MEFs, intense
g-H2AX staining was observed in Pten/ MEFs (Fig-
ure 5A). Quantitation of the data reveals a 7-fold increase
in the number of Pten/ cells positive for g-H2AX com-
pared to Pten+/+ MEFs (29.5% versus 4.1%), suggesting
that DSBs accumulate in the absence of PTEN. To confirm
these results, we examined the distribution of p53-binding
protein 1 (53BP1), another common marker of DSBs,
which colocalizes with g-H2AX (Schultz et al., 2000), using
immunofluorescence in Pten+/+ and Pten/ MEFs. Con-
sistent with g-H2AX staining, a much higher percentage
of Pten/MEFs also displayed intense 53BP1 foci, which
is similar to the g-H2AX staining results and further indi-
cates the accumulation of DSBs (Figure 5B). To further
verify the spontaneous accumulation of DNA-strand
breaks in the absence of PTEN, the alkaline comet assayCell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 163
Figure 5. Accumulation of DNA DSBs
and Reduction of Rad51 in Pten Null
MEFs
(A) Loss of PTEN leads to increased DSB for-
mation. Exponentially growing Pten+/+ and
Pten/ MEFs were fixed and immunostained
for g-H2AX (fluorescein). The cells were coun-
terstained with DAPI.
(B) Increased percentage of p53-binding pro-
tein 1 (53BP1) positive cells in Pten/ MEFs.
Pten+/+ and Pten/ MEFs were stained with
an anti-53BP1 antibody. Results are expressed
as the mean ± the standard error of the mean
(SEM).
(C and D) High incidence of DNA breakage in
Pten null cells. Alkaline comet analysis was
performed on exponentially growingMEFs pro-
ficient and deficient in Pten. At least 125 ran-
domly chosen comets were captured, and the
tail moment was analyzed using Euclid Comet
Analysis software. The representative comets
from wild-type and Pten null MEFs are illus-
trated. (C) shows the percent distribution of
cells with different comet tail moments for
each cell line. (D) illustrates the mean tail
moment. Error bars represent the SEM.
(E) Disruption of Pten results in a reduction in
Rad51 transcription. Northern blotting was per-
formed with radio-labeled cDNA probes for
mouse Rad51 and with a b-actin probe as
a loading control.
(F) Detection of Rad51 protein in MEFs. Cell ly-
sates from MEFs were subjected to western
blotting using anti-Rad51 or anti-actin anti-
bodies.
(G) In vivo binding of endogenous PTEN to
chromatin encompassing the Rad51 promoter
in MEFs. ChIP assay was performed using
a PTEN-specific monoclonal antibody or a non-
specific monoclonal antibody (NS-1) and
a ChIP kit (UBI) according to the manufac-
turer’s protocol. The PTEN-associated Rad51
promoter was amplified by PCR (lanes 3–5).
The input promoter from cell lysates prior to im-
munoprecipitation (IP) was amplified by PCR
as a positive control (lanes 1 and 2).was performed in both Pten+/+ and Pten/ MEFs. In
agreement with 53BP and g-H2AX staining, the alkaline
comet assay revealed a greater number of DNA-strand
breaks in Pten/ MEFs relative to Pten+/+ MEFs (Figures
5C and 5D). Comets with a tail moment greater than
5 were consistently observed in Pten null cells, indicat-
ing that there is extensive spontaneous DNA-strand
breakage.
PTEN Is Necessary and Sufficient for Induction
of Rad51 and DSB Repair
The observed spontaneous accumulation of DSBs led
us to the hypothesis that DNA repair is impaired in the
absence of PTEN. DNA repair is an essential process for
preserving genome integrity in all organisms. To test the
possibility that the DSB-repair deficiency is due to altered164 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.expression of key DNA-repair genes in Pten null cells, we
used cDNAmicroarrays to assess global gene-expression
profiles and, in particular, the expression levels of DSB-re-
pair genes in both Pten+/+ and Pten/ MEFs. Interest-
ingly, we found a markedly decreased level of Rad51 in
Pten/ MEFs compared with Pten+/+ MEFs (data not
shown). Rad51 is an essential component of a homol-
ogy-directed DSB-repair complex (Hays et al., 1995; Shi-
nohara et al., 1992). Loss of Rad51 or its associated pro-
teins impairs the complex from functioning in DSB repair
and is implicated in chromosomal instability (Thacker,
2005). As shown in Figure 5E, the level of Rad51 transcript
is much lower in Pten/MEFs than in Pten+/+ MEFs (lane
1 versus lane 2). Consistently, the level of Rad51 protein is
also greatly reduced in Pten/ MEFs (Figure 6F, lane 1
versus lane 2). Interestingly, Rad51 expression remains
Figure 6. Suppression of DSBs by the
PTEN-Rad51 DSB-Repair Pathway
(A) Ectopic expression of Rad51 in Pten/
MEFs. A mouse Rad51-expression vector,
pcDNA3/mRad51, was introduced intoPten/
MEFs. The levels of Rad51 protein were
measured by western analysis using a Rad51
antibody.
(B) Reduced DSB foci in Pten//mRad51
MEFs. Growing cells as indicated were fixed
for immunofluorescent staining with the anti-
phospho H2AX (Ser139) antibody as a marker
for DSBs. Propidium iodide (PI) was used for
counterstaining.
(C) Induction of Rad51 by PTEN in human PC-3
prostate cancer cells. Protein extracts from
PC-3 cells expressing PTEN or the corre-
sponding control cells were processed for
western blotting using anti-PTEN or anti-
Rad51 antibodies.
(D) Diminished DSB formation in PC-3 cells
expressing ectopic PTEN. DSBswere detected
in the indicated cell clones, as described in (C).
(E) Northern analysis of Rad51 transcription in
PC-3 prostate cancer cells.
(F) Physical association of PTEN with the
Rad51 promoter in vivo. ChIP assay was per-
formed using the PTEN-specific monoclonal
antibody. The PTEN-associated Rad51 pro-
moter was amplified by PCR using correspond-
ing primers. The input DNA from cell lysates
prior to IP was used as a positive control.unchanged in p53/ MEFs (Figure 5F, lane 1 versus lane
3). Because loss of PTEN reduces Rad51 transcription, it
is possible that PTEN functions on chromatin encompass-
ing the promoter of the Rad51 gene. To test this possibil-
ity, we conducted a chromatin-immunoprecipitation
(ChIP) assay to immunoprecipitate the PTEN-associated
chromatin containing the mouse Rad51 promoter. As
shown in Figure 5G, the mouse Rad51 promoter was
PCR-amplified from ChIP products of Pten+/+ MEFs
(lane 3) but not from Pten/ MEFs (lane 4) or a control
with a nonspecific antibody (NS-1, lane 5). These results
suggest that endogenous PTEN is associated with chro-
matin encompassing the mouse Rad51 promoter in vivo.
The reduced level of Rad51 (Figures 5E and 5F) pre-
sumably impairs the ability of Pten null cells to repair
DSBs, which may directly account for the increased
DSB foci in Pten/ MEFs (Figure 5A). In order to test
this hypothesis, we introduced a mouse Rad51 expres-
sion vector, pcDNA3/mRad51, into Pten/ MEFs and
re-examined the formation of DSB foci. As expected, an
increased level of Rad51 was detected in Pten/ MEF/
mRad51 cells (Figure 6A). Consistently, the number of
g-H2AX foci was diminished in Pten/ cells expressing
ectopic Rad51 (Figure 6B). Seven times fewer g-H2AX-
positive cells were found in the Pten/ MEF/mRad51
cell population than in the Pten/ MEFs containing the
control vector (4.2% ± 0.5% versus 29.4% ± 2.1%).
Ectopic expression of Rad51 in the Pten null backgroundreduced DSB formation to a level comparable to that of
Ptenwild-type cells, indicating a restoration of DSB-repair
function. These results are consistent with our hypothesis
that the low level of Rad51 in Pten/ MEFs is insufficient
to accommodate efficient DSB repair, allowing spontane-
ous DSBs to accumulate. Because Rad51 is decreased
due to the loss of PTEN, it is conceivable that PTEN regu-
lates Rad51 expression. Also, since ectopic expression
of Rad51 re-establishes functional DSB repair when
PTEN is absent, Rad51 is a downstream mediator of
PTEN function in DNA repair. Thus, our data reveal a
PTEN-Rad51 signaling cascade that constitutes an
essential DSB-repair pathway in which PTEN regulates
Rad51 in order to alleviate DNA damage and maintain
chromosomal integrity.
To further evaluate the molecular link between PTEN
and regulation of Rad51, we used human PC-3 prostate
cancer cells harboring biallelic PTEN mutations (Vlietstra
et al., 1998) to assess the regulation of Rad51 expression.
Consistent with Pten/ MEFs, the level of human Rad51
is also low in PC-3 cells (Figure 6C). To investigate the reg-
ulatory role of PTEN in Rad51 expression, we introduced
a human PTEN-expression vector, pcDNA3/PTEN, into
PC-3 cells and selected for further studies three stable
cell lines with high levels of PTEN (Figure 6C). As shown
in Figure 6C, Rad51 expression is dramatically induced
in all three PC-3 cell clones overexpressing ectopic
PTEN. These results provide further evidence for theCell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 165
Figure 7. Synergistic Regulation of
Rad51 by PTEN and E2F-1
(A) Transactivation of the Rad51 promoter by
PTEN and E2F-1. PC-3 cells were transiently
transfected with respective plasmids indicated
for luciferase activity. The results are repre-
sented as means ± standard deviation of tripli-
cate cultures and transfections. Luciferase
activity is shown as fold induction.
(B) Induction of Rad51 expression in PC-3
cells. The levels of Rad51 were evaluated by
western analysis of Rad51.
(C) Physical interaction between E2F-1 and the
Rad51 promoter in vivo. ChIP assay was per-
formed to detect the E2F-1-associated mouse
Rad51 promoter from E2F-1+/+ and E2F-1/
MEFs using an anti-E2F-1 antibody. The
mouse Rad51 promoter was amplified by
PCR from either direct genomic DNA as input
(lanes 1 and 2) or anti-E2F-1 immunoprecipi-
tated DNA (lanes 3 and 4).
(D)Western analysis of expression of PTEN and
Rad51 in E2F-1+/+ and E2F-1/ MEFs.regulatory link between PTEN and Rad51 in human cells.
To determine whether the ectopic PTEN alone with the
increased level of Rad51 can ameliorate the defect in
DSB repair, we examined g-H2AX foci formation in these
cells. While nearly half the PC-3 cell population containing
the control vector showed positive g-H2AX foci staining
(46.7% ± 2.7%), it was only apparent in less than 10% of
cells from the clones expressing ectopic PTEN (8.7% ±
0.8% for PC-3/PTEN-c11, as shown in Figure 6D). The
fact that accumulation of DSBs in Pten/ MEFs as well
as PC-3 cells harboring mutant PTEN can be diminished
by ectopic expression of either Rad51 (Figure 6B) or
PTEN (Figure 6D) further suggests that PTEN and Rad51
participate in a common DNA-repair pathway. The func-
tional link between PTEN and Rad51 may derive from
the upregulation of Rad51 by PTEN (Figure 6C). To test
whether this regulation occurs at the transcriptional level,
the RNA level of Rad51 was examined by northern analy-
sis. Consistent with the increased protein levels (Fig-
ure 6C), the abundance of Rad51 transcript is greatly ele-
vated in all three PC-3/PTEN cell clones (Figure 6E, lane 1
versus lanes 2–4). These results and the data from Figure 5
strongly suggest that PTEN could be involved in the tran-
scriptional regulation of Rad51 and that PTEN may do so
by acting on chromatin or its promoter. We performed
a ChIP assay to detect the physical interaction between
PTEN and chromatin containing the human Rad51 pro-
moter. A PTEN monoclonal antibody was used to precip-
itate chromatin from PC-3 cells with or without ectopic
PTEN. Primers specific for the human Rad51 promoter
were used in PCR amplification of genomic DNA (Fig-
ure 6F, lanes 1–4) and of anti-PTEN precipitated DNA
(Figure 6F, lanes 5–8). Consistent with our data from
mouse ChIP (Figure 5G), the PTEN-bound Rad51 pro-
moter was detected from chromatin of PC-3 cells166 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.expressing PTEN (PC-3/PTEN; Figure 6F, lanes 6–8) but
not from the PC-3/pcDNA3 control cells (Figure 6F, lane
5). The Rad51 promoter was undetectable when the
PTEN-specific antibody was replaced with an irrelevant
antibody (NS-1; data not shown). These data suggest
that PTEN functions on chromatin, where the Rad51 pro-
moter is located in vivo, presumably to regulate its tran-
scription. This would imply that the observed increase in
Rad51 transcription following PTEN overexpression could
result from the association of PTEN with the Rad51
promoter and the activation of transcription through an
as-yet-unknown mechanism.
Synergistic Regulation of Rad51 by PTEN and E2F-1
In order to determine whether PTEN directly activates the
promoter of Rad51, we generated a luciferase reporter for
the Rad51 promoter by cloning the human Rad51 pro-
moter into a pGL3-basic vector (pGL3/Rad51-luc). The
Rad51 promoter-luciferase reporter was used together
with a PTEN-expression vector in a luciferase assay to
test whether PTEN increases the luciferase activity. How-
ever, PTEN overexpression failed to induce the luciferase
activity in this luciferase assay (Figure 7A), indicating that
PTEN may not be in direct contact to the promoter. Thus,
PTEN may influence Rad51 expression through a mecha-
nism other than that of direct activation of the Rad51 pro-
moter. In an effort to identify PTEN-associated proteins
through a pull-down assay using His-tagged PTEN protein
as bait, we identified transcription factor E2F-1 as a poten-
tial PTEN-associated protein (data not shown). Interest-
ingly, there is a consensus E2F-1-binding site in the
Rad51 promoter close to the transcription start site (data
not shown). We thus tested whether E2F-1 influences
the activity of the Rad51 promoter. Indeed, E2F-1 does
transactivate the Rad51 promoter (Figure 7A).
Interestingly, PTEN can significantly increase the pro-
moter activity induced by E2F-1 (Figure 7A). The levels
of Rad51 protein are increased in PC-3 cells expressing
E2F-1 alone but higher in PC-3 cells expressing both
PTEN and E2F-1 (Figure 7B, lane 2 versus lane 3). We
also examined the association of E2F-1 and the Rad51
promoter by the ChIP assay using an anti-E2F-1 antibody
to pull down the E2F-1-bound Rad51 promoter in MEFs.
Indeed, the Rad51 promoter was amplified from the anti-
E2F-1 antibody immunoprecipitates from E2F-1+/+ MEFs
but not from E2F-1/ MEFs (Figure 7C, lane 3 versus
lane 4), indicating that E2F-1 binds the Rad51 promoter
in vivo. Consistently, the levels of Rad51 are reduced in
E2F-1/ MEFs (Figure 7D, lane 1 versus lane 2). Our re-
sults demonstrate that PTEN and E2F-1 are both neces-
sary for induction of Rad51 and that PTEN and E2F-1 co-
operate to control Rad51 expression. Because PTEN is
associated with chromatin encompassing the promoter
of Rad51 but unable to activate the Rad51 promoter di-
rectly, PTEN may be a modulator that affects chromatin
remodeling and thus influences transcription of Rad51
by E2F-1. Synergistic regulation of Rad51 by PTEN and
E2F-1 provides a molecular basis for the PTEN-Rad51
signaling cascade, which may play an essential role in
DNA repair and chromosomal stabilization.
DISCUSSION
In this report, we demonstrate that PTEN maintains
chromosomal integrity through two novel pathways: (1)
physical interaction with CENP-C to maintain centro-
mere stability and (2) transcriptional regulation of
Rad51 to control DSB repair and to suppress chromo-
somal instability arising due to DSBs. Because centro-
mere fragmentation appears at an extraordinarily high
frequency, we designated it as a signature phenotype
of PTEN dysfunction. Importantly, PTEN localizes at cen-
tromeres and associates with CENP-C, a constitutive
protein component of the centromere. Residing at the ki-
netochore organizing center (Choo, 2000), CENP-C is
essential for centromere formation (Fukagawa et al.,
1999). Centromere localization of PTEN may depend
on its physical association with CENP-C, which could
target PTEN to the inner core of the centromere/kineto-
chore complex. PTEN may be critical in controlling the
dynamic organization of the centromere, which would
explain why loss of PTEN leads to extensive centromere
breakage. Because CENP-C binds to the DNA back-
bone, CENP-C-associated PTEN may play a critical
role in maintaining chromosomal structure through
centromere stabilization.
The current understanding of PTEN function is primarily
based on its enzymatic activity as a phosphatase that in-
hibits the PI3-K/AKT signaling cascade. In this study, we
unraveled a novel nuclear function of PTEN in ensuring
centromere stability independent of its ability to regulate
the PI3-K/AKT pathway. The mutant PTEN lacking phos-phatase activity retains its association with centromeres,
suggesting that PTEN’s association with centromeres
is independent of its phosphatase function. If the PTEN-
centromere interaction were critical for maintaining cen-
tromere integrity, one would expect that disruption of their
association would lead to chromosomal instability. Inter-
estingly, we found that PTEN189, a truncated mutation
of PTEN lacking its C terminus, no longer associates
with CENP-C. Dramatically, this PTEN mutant causes
significant chromosomal aberrations when ectopically
expressed in normal mouse and human cells, suggesting
that it can behave as a dominant-negative mutant. Indeed,
we found that PTEN189 can physically bind endogenous
wild-type PTEN and disrupt the association of wild-type
PTEN with centromeres. In cells expressing PTEN189,
PCS occurs at a very high frequency, which likely indi-
cates a disturbance in the normal process of chromo-
somal segregation. In support, normal cells transfected
with PTEN189 become highly aneuploid. The importance
of PTEN association with centromeres in centromeric
stability is further confirmed by characterization of another
mutant PTEN, PTEN233, as a recessive mutation. Our
data suggest that the association of PTEN with centro-
meres is essential for chromosomal stability and that
mutant PTEN lacking this associative property disrupts
chromosomal integrity. Interestingly, these mutant forms
of PTEN were originally identified in Cowden syndrome,
a cancer-susceptibility syndrome (Eng, 2003). Thus, it is
plausible that these types of PTEN mutants may act as
oncogenes and promote tumorigenesis by destroying
chromosomal stability. Indeed, some Cowden syndrome
patient-derived lymphoblast cells harboring PTEN muta-
tions outside the phosphatase domain exhibit centromere
instability. Our results demonstrate that PTEN functions at
centromeres in a phosphatase-independent manner and
that the C terminus of PTEN is essential for PTEN action
as a tumor suppressor. This would explain why PTEN is
frequently mutated outside its phosphatase domain or in
the C-terminal region in human cancer (Eng, 2003; Waite
and Eng, 2002). Our data provide insights into a new
mechanismwhereby C-terminal mutations of PTEN cause
chromosomal instability, which may contribute to the
development of breast and thyroid cancers in patients
with Cowden syndrome.
Because PTEN is necessary for the basal expression
of Rad51, we propose that PTEN may participate in the
DNA-repair process through regulation of Rad51. PTEN
is physically associated with chromatin encompassing
the Rad51 promoter in vivo; it is thus possible that PTEN
acts on chromatin and influences transcription. Interest-
ingly, E2F-1 is also associated with the Rad51 promoter
and transactivates the Rad51 gene. The fact that both
PTEN and E2F-1 are necessary for transcriptional activa-
tion of the gene suggests that PTEN and E2F-1 synergis-
tically regulate Rad51 transcription. Our data provide a
potential mechanism by which PTEN acts on chromatin
and modulates gene expression through cooperation
with conventional transcription factors.Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc. 167
It has been reported that Rad51 is critical for chromo-
somal stability, presumably through controlling DSB
repair (Smiraldo et al., 2005). Therefore, the novel PTEN-
Rad51 DNA-repair pathway uncovered in this study
provides a mechanistic basis for a DSB-repair defect in
Pten null cells that can give rise to chromosomal breakage
and translocations. We speculate that dysfunction of
this PTEN pathway may be responsible for the increased
chromosomal instability frequently observed in tumors
with mutant PTEN. The notion that PTEN functions in
maintaining genomic stability is supported by a recent
report that lack of PTEN is associated with an increased
prevalence of aneuploidy in human breast primary carci-
noma (Puc et al., 2005). This study suggests that PTEN
suppresses aneuploidy through regulation of CHK1 loca-
tion. Loss of PTEN results in the activation of AKT, leading
to CHK1 phosphorylation and cytoplasmic sequestration
of CHK1 from the nucleus. Thus, this PTEN function in
the cytoplasm depends upon its phosphatase activity.
However, our studies demonstrate that PTEN controls
chromosomal stability through physical association with
centromeresand that thisnuclear functionofPTEN isphos-
phatase independent. Therefore, it is clear that nuclear
PTEN and cytoplasmic PTEN have different functions.
In summary, as illustrated in Figure S4, we demonstrate
that PTEN is essential for maintaining chromosomal integ-
rity through multiple mechanisms. We show that PTEN
controls chromosomal stability through its physical as-
sociation with centromere protein in a phosphatase-
independent manner and that the C terminus of PTEN is
essential for its tumor-suppressor function. We also reveal
a crucial role of PTEN in DSB repair and establish amolec-
ular link between nuclear PTEN and a DSB-repair pathway
through regulation of Rad51. Therefore, we propose that
PTEN is a major guardian of chromosomal structure and
function, which represents a fundamental role for PTEN
in the maintenance of genomic stability.
EXPERIMENTAL PROCEDURES
Cell Lines, Construction of PTEN, and Rad51 Plasmids
Primary MEFs were prepared as described elsewhere (Sun et al.,
1999). Primary Pten+/+ and Pten/ MEFs at passages 2–3 were
cultured under normal growth conditions. Pten+/+ and Pten/ ES cells
were generated previously (Sun et al., 1999). The ES cells were grown
in a Knockout DMEM from GIBCO. E2F-1+/+ and E2F-1/MEFs were
describedelsewhere (Yamasaki et al., 1996).HumanPTEN- andmouse
Rad51-expression plasmids were created by ligating the full-length
coding region of either human PTEN or mouse Rad51 into the select-
able constitutive-expression vector pcDNA3.1 (Invitrogen), resulting
in pcDNA3/hPTEN and pcDNA3/mRad51. pcDNA3/PTEN189 was
generated by changing codon 189 from AGA for arginine to a TGA
stop codon of human PTEN using the QuikChange site-directed
mutagenesis kit (Stratagene) according to the manufacturer’s proto-
col. Other constructs are described in Supplemental Experimental
Procedures.
Chromosomal Analysis by T-FISH and M-FISH
Metaphase chromosome spreads were prepared from exponentially
growing cells after treatment with demecolcine (0.1 mg/ml) for 4 hr
using a standard procedure. T-FISH was performed using a Cy3-168 Cell 128, 157–170, January 12, 2007 ª2007 Elsevier Inc.labeled peptide nucleic acid probe. For T-FISH, both the DNA probe
and the slides were heat denatured (80C for 5 min) and hybridized
at 37C for 2 hr. M-FISH was performed in accordance with the
manufacturer’s specifications (MetaSystems). Slides were counter-
stained with DAPI, and the images were captured using an Axioplan
2 imaging microscope (Zeiss) equipped with the Isis software program
by MetaSystems.
Immunofluorescence and Confocal Microscopy
Cells were grown in 2-well chamber slides to exponential growth
phase and fixed in acetone-methanol at a ratio of 1:1. DSB foci were
detected by immunostaining with a monoclonal antibody to g-H2AX
(UBI) or a polyclonal antibody to 53BP1 (Santa Cruz) followed by incu-
bation with a fluorescein- or Texas-red-conjugated secondary anti-
body. Colocalization of PTEN with centromere was detected by using
a double immunofluorescent procedure. Pten+/+ and Pten/ MEFs
grown in 2-well chamber slides were fixed and incubated with both
an anti-PTEN monoclonal antibody (Santa Cruz) or homemade anti-
full-length PTEN polyclonal antibody and the human CREST autoim-
mune sera against centromere/kinetochore antigens (ImmunoVision).
Cells were then stained with a fluorescein-conjugated antimouse
immunoglobulin G (IgG) and a Texas-red-conjugated antihuman IgG
(Jackson Laboratories). Images were analyzed using a laser-scanning
confocal microscope (Nikon).
CoIP and Western Blotting
CoIP of PTEN and centromere components was performed in Pten+/+
and Pten/ MEFs. Equal amounts of protein were incubated with
a PTEN monoclonal antibody (Cell Signaling Technology, Inc.). The
PTEN immunocomplexes were precipitated by protein G-Sepharose
and subsequently subjected to immunoblotting with the CREST
human autoantibody recognizing centromeres or a specific polyclonal
antibody against CENP-C (Santa Cruz). IP-western analysis of PTEN-
centromere association was also performed using the anti-centromere
antibody for IP and a homemade anti-full-length PTEN polyclonal
antibody for western blotting in the presence of ExactaCruz reagents
to reduce the IgG background. For western blotting, immunoprecipi-
tates or cell lysates were resolved in 10% SDS-polyacrylamide gels
and then transferred onto a nitrocellulose filter. The blots were incu-
bated with primary antibodies and then with peroxidase-conjugated
species-matched secondary antibodies.
ChIP
The ChIP assay was performed using a ChIP kit (UBI) according to the
manufacturer’s protocol as described in Supplemental Experimental
Procedures.
Supplemental Data
Supplemental Data include four figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/128/1/157/DC1/.
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